ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Kailera Therapeutics, Inc.
16.00
0.0000
成交量:
- -
成交額:
- -
市值:
18.87億
市盈率:
- -
高:
- -
開:
- -
低:
- -
收:
16.00
52周最高:
- -
52周最低:
- -
股本:
1.18億
流通股本:
3,333.33萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
淨資產收益率:
-36.90%
總資產收益率:
-22.73%
市淨率:
-5.29
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
募資6.25億美元創五年之最 減肥藥新貴Kailera Therapeutics(KLRA.US)今晚登陸納斯達克
智通财经
·
7小時前
減肥藥公司Kailera Therapeutics(KLRA.US)IPO定價14-16美元/股 擬周五登陸納斯達克
智通财经
·
04/14
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/KLRA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KLRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRA\",,,,,undefined,":{"symbol":"KLRA","market":"US","secType":"STK","nameCN":"Kailera Therapeutics, Inc.","latestPrice":16,"timestamp":1776369600000,"preClose":16,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":33333334,"shares":117948773,"eps":0,"marketStatus":"待開盤","change":0,"latestTime":"04-16 16:00:00 EDT","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1776432600000},"marketStatusCode":16,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":16,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLRA\",,,,,undefined,":{"symbol":"KLRA","floatShares":33333334,"roa":"-22.73%","roe":"-36.90%","lyrEps":0,"shares":117948773,"dividePrice":0,"high":0,"amplitude":0,"preClose":16,"low":0,"week52Low":0,"pbRate":"-5.29","week52High":0,"institutionHeld":0,"latestPrice":16,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KLRA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KLRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KLRA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KLRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KLRA","date":"2026-04-16","current":-11.877625,"percent":1,"low":-11.877625,"twenty":-11.877625,"median":-11.877625,"eighty":-11.877625,"high":-11.877625,"avg":-11.877625,"sd":0,"marketCap":1769231595},"quantilePoints":[{"date":"2026-04-16","current":-11.877625,"twenty":-11.877625,"median":-11.877625,"eighty":-11.877625,"marketCap":1769231595}],"updateTime":1776417822448},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KLRA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2628221198","title":"募資6.25億美元創五年之最 減肥藥新貴Kailera Therapeutics(KLRA.US)今晚登陸納斯達克","url":"https://stock-news.laohu8.com/highlight/detail?id=2628221198","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628221198?lang=zh_tw&edition=fundamental","pubTime":"2026-04-17 11:33","pubTimestamp":1776396818,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,专注于肥胖症治疗的临床阶段生物科技公司Kailera Therapeutics Inc.通过扩大首次公开发行规模,成功募资6.25亿美元,创下2021年以来美国生物科技领域规模最大的IPO纪录。根据周四发布的一份声明,Kailera以每股16美元的价格出售了约3900万股股票。包括贝恩资本旗下Bain Capital Private Equity、Bain Capital Life Sciences和卡塔尔投资局在内的现有股东已表示,有意按IPO价格合计购买最多2.25亿美元的公司股票。此次IPO之前,Kailera已于去年10月通过B轮融资募资6亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["QQQY","FTEC","NVIW.SI","QID","SQQQ","BK4007","QQQJ","QLD","QQQE","QQQM","BK4139","JEPQ","QDTE","QQQA","QYLG","PSQ","TQQQ","GPIQ","QQQ","BK1147","ONEQ","KLRA","MNQmain","TQQY","IYW","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627741817","title":"減肥藥公司Kailera Therapeutics(KLRA.US)IPO定價14-16美元/股 擬周五登陸納斯達克","url":"https://stock-news.laohu8.com/highlight/detail?id=2627741817","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627741817?lang=zh_tw&edition=fundamental","pubTime":"2026-04-14 15:19","pubTimestamp":1776151188,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,专注于开发治疗肥胖症注射及口服GLP-1类药物的III期阶段生物技术公司Kailera Therapeutics于周一公布其首次公开募股条款。根据计划,Kailera 预计将于本周四晚间完成最终定价,并于次日在纳斯达克交易所挂牌交易。其核心候选药物ribupatide目前正在全球开展III期临床试验,这是一种每周一次注射的GLP-1/葡萄糖依赖性促胰岛素多肽受体双重激动剂肽。Kailera Therapeutics成立于2024年,计划在纳斯达克上市,股票代码为KLRA。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MNQmain","JEPQ","QYLG","QQQJ","PSQ","ONEQ","NVIW.SI","KLRA","BK4007","QQQ","QQQA","QID","QQQY","BK4139","IYW","BK4539","SQQQ","QQQM","BK1147","TQQQ","FTEC","QLD","QQQE","TQQY","GPIQ","QDTE"],"isVideo":false,"video":null,"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}